Driven by excellence, focused on strategies for the longer term.

This is the crux of who we are. It is an articulation of precision in purpose, from the Firm’s beginnings to where we are today. Our collective eye is unerringly trained on tomorrow.

Deep sectoral expertise across services and industries.

Our insistence on strategic advisory exacts an in-depth understanding of and involvement with our clients’ businesses and industries. We engage not just individual businesses, but also contribute to the country’s legal and regulatory frameworks.

Personal commitment supported by experience and grit.

We commit early. We pull together internally for greater support. Every effort is sincere, every individual deeply dedicated to their task, their role, to the Firm.

Our undertakings for long-term impact are an organic extension of our purpose.

They are to employ our deep knowledge of the law beyond the business, the transaction, the deal. To use the opportunities and skills we possess, to reflect on the culture we’re creating. Individually and collectively, these are our efforts to help shape the thinking of our future generations, and arm them with strategies for true, sustainable growth.

Knowledge-sharing is intrinsic to equity and inclusivity.

This is a repository of thought leadership, deep insights and strong viewpoints, legal and other news and events and how they impact the industry and our clients.

Relevance is critical to growth. It necessitates a firm that is dynamic and responsive.

Amplifying intrinsic talent, sharpening skills, expanding knowledge, is vital to leading. It defines every aspect of how our firm functions and transacts. This is how we create new benchmarks and set industry standards.

  • Connect
May 09, 2025

TPG on its acquisition of 35% stake in SCHOTT Poonawalla Private Limited.

AZB & Partners is acting for TPG on its acquisition of a 35% stake in SCHOTT Poonawalla Private Limited, from the Serum Institute of India Private Limited (SII). SCHOTT Poonawalla Pvt Ltd is a joint venture of SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group.

Our AZB deal team comprises our Senior Partner Nandish Vyas, Partner Devika Nayak, Senior Associates Karun Jhangiani, Anish Patel and Tanay Chopra and Associates Shivam Gupta and Rishav Sen. They were supported on the due diligence aspects by our Partners, Ajay Singh Solanki and Shivanand Nayak, Senior Associates Sherna Doongaji, Veeral Vakharia, Rhea Ghanshani, and Sneh Choudhary, Associates Rishad Mehta, Shloka Jain, Shraddha Sethia, Siddharth Tandon, Vikrant Dwivedi, Yashashwini Santuka, Akilesh Menezes, Janhavi Rajkumar, Mayukh Mandal, Pratyush Chaturvedi, Avani Laad, Gaurav Jayakumar, Ria Doshi; on the CCI aspects by our Senior Partner Bharat V Budholia, Senior Associates Vayshnavi Ganesh and Deepanshu Poddar and Associates Shaurya Kumar and Ojaswi Bhagat.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

Subscribe

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.

RELATED READING

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for: